General Atlantic Portfolio
Our portfolio companies are already on a strong growth trajectory — our goal is to enhance it. We have a solid track record of delivering strategic, practical and impactful support to our portfolio companies.
Karuna Therapeutics ×
Karuna Therapeutics is a clinical-stage biotechnology company developing a novel oral drug for schizophrenia and Alzheimer's Disease related psychosis.